Geron (GERN) Exchange Rate Effect (2022 - 2026)
Geron (GERN) posted Exchange Rate Effect of -$36000.0 for Q1 2026, down 300.0% sequentially from -$9000.0 in Q4 2025, and down 300.0% YoY from $18000.0 in Q1 2025.
Geron (GERN) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Geron has reported Exchange Rate Effect for 4 years, with the latest figure at -$36000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 300.0% year-over-year to -$36000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33000.0 (up 106.25% YoY) and the FY2025 annual result came in at $87000.0, up 825.0% from the prior year.
- Exchange Rate Effect retreated to -$36000.0 in Q1 2026 per GERN's latest filing, from -$9000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $75000.0 in Q3 2025 and troughed at -$36000.0 in Q1 2026.
- A 4-year average of $4000.0 and a median of -$4000.0 in 2022 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect jumped 280.0% in 2025, then plunged 300.0% in 2026.
- Over 4 years, Exchange Rate Effect stood at $1000.0 in 2022, then sank by 3000.0% to -$29000.0 in 2024, then surged by 68.97% to -$9000.0 in 2025, then slumped by 300.0% to -$36000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$36000.0, -$9000.0, and $75000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.54 Bn | 130.69 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.89 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.84 Bn | 59.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.53 Bn | 51.39 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Geron | 1.01 Mn | -299.84 Mn | - | -100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -100,000.00 |
| Jun 30, 2026 | -100,000.00 |
| Mar 31, 2026 | -36,000.00 |
| Mar 31, 2026 | -36,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | -29,000.00 |
| Dec 31, 2024 | -29,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | -21,000.00 |
| Jun 30, 2024 | -21,000.00 |
| Mar 31, 2024 | -10,000.00 |
| Mar 31, 2024 | -10,000.00 |